RA Capital Nexus Fund, L.P., Director, 10% Owner at Vor Biopharma Inc. (VOR), sold 232,813 shares at $29.63 ($6.8M) on 2025-10-20, disclosed to the SEC on 2025-10-22.
Open-market sale of $6.8M VOR by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.63 | 13,817 | $409K | 6.0% |
| 2 | $29.63 | 70,366 | $2.1M | 30.5% |
| 3 | $29.63 | 70,366 | $2.1M | 30.5% |
| 4 | $29.63 | 13,817 | $409K | 6.0% |
| 5 | $30.12 | 1,287 | $39K | 0.6% |
| 6 | $30.12 | 6,553 |
| $197K |
| 2.9% |
| 7 | $30.12 | 6,553 | $197K | 2.9% |
| 8 | $28.11 | 25,027 | $704K | 10.3% |
| 9 | $28.11 | 25,027 | $704K | 10.3% |
| Total | $29.33 avg | 232,813 | $6.8M | 100% |
| Filing → |
| ETNB | BUY | 2022-07-06 | $10.0M | — | Filing → |
| TYRA | BUY | 2021-09-17 | $20.0M | — | Filing → |